Lyumjev Global Market Report 2025: Epidemiology, Pipeline Analysis, Market Insights & Forecasts

The lyumjev market research report is one of a series of new reports that provides lyumjev market statistics, including the lyumjev industry global market size, regional shares, competitors with the lyumjev market share, detailed lyumjev market segments, market trends, and opportunities, and any further data you may need to thrive in the lyumjev industry. This lyumjev market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The growth in the forecast period can be attributed to rising urbanization, increasing price of insulin, and expansion of indications, growing sedentary lifestyle, rising disposable income, and increased research funding. Major trends in the forecast period include technological integration, advances in diabetes research, innovations in long-acting insulin products, shifts towards healthier lifestyles, and collaborations and partnerships.

The increasing prevalence of diabetes is expected to significantly drive the growth of the lyumjev market in the coming years. Diabetes refers to a group of chronic conditions that affect the body's ability to regulate blood sugar levels. This rise in diabetes cases is largely due to factors such as poor dietary habits, sedentary lifestyles, genetic factors, and an aging population. Lyumjev aids in controlling blood sugar by providing fast-acting insulin, which helps to quickly lower blood sugar spikes after meals. According to Diabetes Canada, the number of people diagnosed with diabetes (both type 1 and type 2) reached 4,006,850 in 2024, with projections suggesting that number will rise to 5,300,670 by 2034. As a result, the increasing prevalence of diabetes is fueling demand for lyumjev.

The growing trend of sedentary lifestyles is also expected to play a significant role in driving the lyumjev market. Sedentary lifestyles involve behaviors that include minimal physical activity, with individuals spending long periods sitting or lying down. This rise in sedentary habits is often linked to the widespread use of technology, desk-bound jobs, excessive screen time, and reliance on convenient transportation methods, all of which reduce physical movement. Lyumjev is designed to act faster than conventional rapid-acting insulins, quickly lowering blood glucose levels after administration, which can be particularly beneficial for individuals with a sedentary lifestyle who may experience more significant post-meal blood sugar spikes due to limited physical activity. According to the Office for National Statistics, a report from the UK, between April 2021 and March 2022, large percentages of people in older age groups were classified as inactive, with inactivity rates of 15.8% among those aged 50 to 54, 24.1% for those aged 55 to 59, 43.4% for individuals aged 60 to 64, and 89.3% among those aged 65 and older. This increase in sedentary living is contributing to the growth of the lyumjev market.

A key trend in the lyumjev market is the expansion of its indication, including its use for improving glycemic control in children with diabetes. Rapid-acting mealtime insulin is especially useful for children, as it helps control blood sugar levels during and after meals. In October 2022, Eli Lilly and Company, a U.S.-based pharmaceutical firm, received approval from the United States Food and Drug Administration for Lyumjev (insulin lispro-aabc) injection as a rapid-acting mealtime insulin for children. This approval came after the successful results of the PRONTO-Peds phase 3 study, which demonstrated that Lyumjev could be administered during mealtime or up to 20 minutes afterward.

The key company operating in the lyumjev market is Eli Lilly and Company.

North America was the largest region in the lyumjev market in 2024. The regions covered in lyumjev report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the lyumjev market report are Australia, India, China, South Korea, Japan, UK, France, Germany, USA, Canada.

Lyumjev is a rapid-acting insulin formulation designed to help manage blood sugar levels in individuals with diabetes. Its mechanism of action involves the quick absorption of insulin lispro, which aids in regulating blood sugar by promoting glucose uptake into cells, reducing glucose production in the liver, and more effectively controlling post-meal blood sugar spikes.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Lyumjev is primarily indicated for the treatment of type 1 diabetes, type 2 diabetes, and the management of postprandial hyperglycemia. In the case of type 1 diabetes, it works by replacing the insulin the body can no longer produce to help maintain stable blood sugar levels. The medication is available in various forms, including injectable solutions and pre-filled pens (Lyumjev KwikPen). It is prescribed to a broad range of patients, including pediatric, adult, and geriatric populations. Lyumjev is distributed through multiple channels, such as direct sales, wholesalers, distributors, retail pharmacies, and online pharmacies. It is used in various healthcare settings, including hospitals, diabetes clinics, specialty pharmacies, and home healthcare services.

The lyumjev market consists of sales of products including lyumjev U-100, lyumjev U-200, and lyumjev for insulin pumps. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.